To develop and bring to patients new targeted cancer chemotherapy drugs that have reduced side effects and improved effectiveness compared to existing chemotherapy cancer drugs.

IGF Oncology, LLC, a Minnesota company registered in Delaware, was formed to develop its novel and proprietary family of new anti-cancer chemotherapy drugs with reduced toxicity.

The company has now demonstrated in mice that its first candidate drug is more than six times better than the closest conventional chemotherapy drug.

© IGF Oncology, LLC.